WD 40 CO (WDFC) Q4 2025 10-Q Quarterly Report

Filed: Jan 8, 2026Period ending Nov 30, 2025
Health Care
Miscellaneous Chemical ProductsSEC EDGAR

WD 40 CO (WDFC) 10-Q quarterly report for Q4 2025, filed with SEC EDGAR on Jan 8, 2026 for the fiscal period ending Nov 30, 2025. This page provides AI-powered analysis including management discussion & analysis (MD&A), risk factor updates, and key quarterly financial data such as revenue and net income extracted from XBRL.

WD 40 CO Q4 2025 10-Q Analysis

Risk Factors

  • No new or changed risk factors from 10-K filed October 27, 2025
  • Continued exposure to market competition impacting product demand and pricing
+3 more insights

WD 40 CO Q4 2025 Quarterly Financials
XBRL

Revenue

$154M

+0.6% YoY

Net Income

$17M

-7.8% YoY

Gross Margin

56.2%

+145bp YoY

Operating Margin

15.1%

-131bp YoY

Net Margin

11.3%

-103bp YoY

ROE

6.6%

-175bp YoY

Total Assets

$460M

+2.8% YoY

EPS (Diluted)

$1.28

-7.9% YoY

Operating Cash Flow

$10M

-33.1% YoY

Source: XBRL data from WD 40 CO Q4 2025 10-Q filing on SEC EDGAR. All figures in USD.

Get deeper insights on WD 40 CO

Access full AI analysis, insider trading data, fund holdings, and cross-signal detection on SignalX.